Industry Overview - The U.S. cannabis industry generated over $33 billion in sales during 2024, making it one of the fastest-growing consumer sectors, with projections of annual sales surpassing $56 billion by 2030 [1] - Federal rescheduling efforts could ease tax burdens for cannabis companies, while more states are preparing adult-use legalization measures, increasing growth opportunities for multi-state operators [1][5] - The sector is characterized by volatility, necessitating careful evaluation of fundamentals and sector catalysts [1][12] Company Highlights Green Thumb Industries (OTC: GTBIF) - Green Thumb Industries operates over 100 dispensaries across 14 states, focusing on high-demand, limited-license markets, and has confirmed 108 locations with steady growth [3][5] - The company reported quarterly revenue of approximately $293 million in 2025, reflecting a year-over-year increase, with adjusted EBITDA around $83 million and operating cash flow of $56 million [4][5] - Green Thumb has a balance sheet with $177 million in cash, allowing for financial flexibility and continued investment [5] Glass House Brands (OTC: GLASF) - Glass House Brands focuses on California, managing 10 dispensaries and emphasizing large-scale greenhouse cultivation and efficient production [6][8] - The company reported second-quarter revenue of $59.9 million, an 11% year-over-year increase, with gross margins expanding to 53% and adjusted EBITDA of $18.1 million [8] - Cash reserves stood at $44.2 million, and cultivation volume reached 231,000 pounds during the quarter, with costs averaging $91 per pound [8] Cresco Labs (OTC: CRLBF) - Cresco Labs operates 71 Sunnyside dispensaries and focuses on both retail and wholesale, with significant brand development across various product categories [9][10] - The company posted revenue of $164 million in the second quarter of 2025, with an adjusted gross margin of 50.6% and adjusted EBITDA of approximately $41 million [11] - Cresco reported a net loss of $14 million, primarily from non-cash impairments, but has effectively controlled expenses, with selling, general, and administrative expenses at 31% of revenue [11] Investment Considerations - Investors are encouraged to apply technical analysis, monitoring support, resistance, and moving averages to improve timing in this volatile sector [12] - The upcoming catalysts, such as federal rescheduling and new state launches, make these three stocks—Green Thumb, Glass House, and Cresco—worth watching closely [12]
Top Marijuana Stocks to Watch as Federal Reform Advances
Marijuana Stocks | Cannabis Investments And News. Roots Of A Budding Industry.™·2025-09-21 14:00